Complete Regression of Hepatocellular Carcinoma with Low Dose of Sorafenib.
作者信息
Mahajan Abhishek, Shetty Athish, Koteshwar Prakashini, Musunuri Balaji, Shetty Shiran, Bhat Ganesh
机构信息
Department of Gastroenterology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal 576104, India.
Department of Radiodiagnosis, Kasturba Medical College, Manipal Academy of Higher Education, Manipal 576104, India.
出版信息
J Clin Exp Hepatol. 2021 Nov-Dec;11(6):756-757. doi: 10.1016/j.jceh.2021.06.012. Epub 2021 Jun 17.
Abstract
摘要
相似文献
1
Complete Regression of Hepatocellular Carcinoma with Low Dose of Sorafenib.低剂量索拉非尼使肝细胞癌完全消退
J Clin Exp Hepatol. 2021 Nov-Dec;11(6):756-757. doi: 10.1016/j.jceh.2021.06.012. Epub 2021 Jun 17.
2
Complete response of advanced hepatocellular carcinoma achieved by sorafenib dose re-escalation after failure of long-term low-dose-sorafenib treatment combined with transcatheter arterial chemoembolization: a case report.索拉非尼剂量递增治疗晚期肝细胞癌的完全缓解：长期低剂量索拉非尼联合经导管动脉化疗栓塞治疗失败后的病例报告。
Clin J Gastroenterol. 2020 Jun;13(3):397-402. doi: 10.1007/s12328-019-01066-7. Epub 2019 Nov 11.
3
A complete response induced by 21-day sorafenib therapy in a patient with advanced hepatocellular carcinoma.一名晚期肝细胞癌患者经21天索拉非尼治疗后出现完全缓解。
Intern Med. 2013;52(14):1589-92. doi: 10.2169/internalmedicine.52.9340. Epub 2013 Jul 15.
4
Long-term complete response of advanced hepatocellular carcinoma treated with multidisciplinary therapy including reduced dose of sorafenib: case report and review of the literature.采用包括降低剂量索拉非尼在内的多学科治疗方案治疗晚期肝细胞癌的长期完全缓解：病例报告及文献综述
World J Surg Oncol. 2015 Apr 9;13:144. doi: 10.1186/s12957-015-0559-9.
5
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial.索拉非尼辅助治疗肝细胞癌切除术后或消融后（STORM）：一项 3 期、随机、双盲、安慰剂对照试验。
Lancet Oncol. 2015 Oct;16(13):1344-54. doi: 10.1016/S1470-2045(15)00198-9. Epub 2015 Sep 8.
6
Long-Term Maintenance of Complete Response after Sorafenib Treatment for Multiple Lung Metastases from Hepatocellular Carcinoma.索拉非尼治疗肝细胞癌多发肺转移后的完全缓解长期维持
Case Rep Gastroenterol. 2015 Aug 6;9(2):285-90. doi: 10.1159/000438746. eCollection 2015 May-Aug.
7
Starting Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma: A Retrospective, Multi-Institutional Study.索拉非尼治疗肝细胞癌的起始剂量：一项回顾性多机构研究
J Clin Oncol. 2017 Nov 1;35(31):3575-3581. doi: 10.1200/JCO.2017.73.8245. Epub 2017 Sep 5.
8
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.钇[90Y]树脂微球选择性内放射治疗与索拉非尼治疗局部进展期不可切除肝细胞癌的疗效和安全性比较（SARAH）：一项开放标签随机对照 3 期临床试验。
Lancet Oncol. 2017 Dec;18(12):1624-1636. doi: 10.1016/S1470-2045(17)30683-6. Epub 2017 Oct 26.
9
Sorafenib: a review of its use in advanced hepatocellular carcinoma.索拉非尼：其在晚期肝细胞癌中的应用综述
Drugs. 2009;69(2):223-40. doi: 10.2165/00003495-200969020-00006.
10
Complete response to short-term sorafenib treatment alone for hepatocellular carcinoma with bone, lymph node, and peritoneum metastases.索拉非尼短期单药治疗对伴有骨、淋巴结及腹膜转移的肝细胞癌的完全缓解。
Hepatol Res. 2016 Dec;46(13):1402-1408. doi: 10.1111/hepr.12698. Epub 2016 Apr 30.
本文引用的文献
1
2019 Update of Indian National Association for Study of the Liver Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinoma in India: The Puri II Recommendations.印度肝脏研究全国协会关于印度肝细胞癌预防、诊断和管理的共识2019年更新：普里II建议
J Clin Exp Hepatol. 2020 Jan-Feb;10(1):43-80. doi: 10.1016/j.jceh.2019.09.007. Epub 2019 Sep 23.
2
Spontaneous Regression of Hepatocellular Carcinoma and Review of Reports in the Published English Literature.肝细胞癌的自发消退及英文文献报道综述
Case Rep Med. 2019 Mar 31;2019:9756758. doi: 10.1155/2019/9756758. eCollection 2019.
3
Spontaneous regression of hepatocellular carcinoma: A mini-review.肝细胞癌的自发消退：一篇综述。
World J Gastroenterol. 2017 Jun 7;23(21):3797-3804. doi: 10.3748/wjg.v23.i21.3797.
4
Complete pathological regression of hepatocellular carcinoma with portal vein thrombosis treated with sorafenib.索拉非尼治疗伴门静脉癌栓的肝细胞癌完全病理缓解。
World J Surg Oncol. 2013 Aug 2;11(1):171. doi: 10.1186/1477-7819-11-171.
5
Complete regression following sorafenib in unresectable, locally advanced hepatocellular carcinoma.索拉非尼治疗不可切除的局部晚期肝细胞癌后完全缓解。
Future Oncol. 2013 Aug;9(8):1231-7. doi: 10.2217/fon.13.86.
6
Spontaneous regression of hepatocellular carcinoma: a systematic review.肝细胞癌自发消退：系统综述。
Eur J Gastroenterol Hepatol. 2009 Mar;21(3):254-7. doi: 10.1097/MEG.0b013e328324b6a2.
7
Efforts to explain spontaneous regression of cancer.解释癌症自发消退的努力。
J Surg Oncol. 1981;17(3):201-9. doi: 10.1002/jso.2930170302.
Zotero 插件